Rate My Professor Sabatino Ventura

Dr. Sabatino Ventura is a Senior Lecturer in Drug Discovery Biology in the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University. He holds the position of Functional Biology Group Leader within the Medicinal Chemistry and Drug Action theme at the Monash Institute of Pharmaceutical Sciences. His academic responsibilities include serving as a senior lecturer to undergraduate students in the Bachelor of Pharmacy and Bachelor of Pharmaceutical Science programs, where he coordinates physiology and drug action units. Ventura also supervises PhD candidates and Bachelor of Pharmaceutical Science (Honours) students.

Ventura's research specializes in the pharmacology of the male reproductive system, particularly the development of novel, non-hormonal male contraceptives. His group targets the P2X1 purinoceptor to pharmacologically block sperm transport in the epididymis and vas deferens, providing a reversible option that does not affect sperm production or sexual health. Notable projects under his leadership or supervision include "Development of a P2X1 receptor antagonist for use as a male contraceptive" (2025–2027), "Discovery of a lead molecule for development into a non-hormonal male contraceptive" (2023–2024), "Male contraception through pharmacological blockade of sperm transport" (2018–2020), and "Assessment of the Suitability of a Lipid Extract of Saw Palmetto for the Treatment of Benign Prostatic Hyperplasia" (2010–2011). His publication record comprises 63 articles, 20 abstracts, 2 review articles, and 1 short review. Prominent works include "Structural insights into the human P2X1 receptor and ligand interactions" (Nature Communications, 2024), "The P2X1 receptor as a therapeutic target" (Purinergic Signalling, 2022), "Aqueous extracts of Urtica dioica leaf contain a P2-purinoceptor antagonist—Implications for male fertility" (PLoS ONE, 2022), "Synthesis of 2-phenyl-5,6,7,8-tetrahydroquinoxaline derivatives and screening for P2X1-purinoceptor antagonist activity in isolated preparations of rat vas deferens, for translation into a male contraceptive" (Biology of Reproduction, 2020), and "Male contraception via simultaneous knockout of α1A-adrenoceptors" (PNAS, 2013). In 2024, he was a recipient of the Faculty of Pharmacy and Pharmaceutical Sciences Award for Programs that Enhance Learning. His research aligns with UN Sustainable Development Goal 3: Good Health and Well-being.